TP53 and endometrial endometrioid carcinoma: Bearing this in mind, in G3 endometrioid endometrial carcinoma with mutated TP53, aberrant signaling pathways contribute to uncontrolled cell proliferation, genomic instability, and resistance to apoptosis.